Kirin Cashes Out of Amgen Drug Joint Venture for $780M Post author:Sam Post published:October 30, 2017 Post category:BioPharma Amgen and Kirin have decided to dissolve their joint venture, Kirin-Amgen. Source: BioSpace You Might Also Like Boston Scientific To Participate In 2017 Healthcare Conference August 20, 2017 Personalis Receives Approval From For Clinical Tests Based On The ACE Exome April 24, 2017 One To Watch: How Bedfont Scientific Is Changing The Future May 25, 2017
